TP53 and cancer: The tumor showed no other recognized driver alterations, and the only other significant mutation was biallelic loss of TP53. While the latter is a frequent alteration across all cancer histologies29, it has also been more specifically associated with an HRD phenotype in patients with BRCA mutations and with locus-specific loss of heterozygosity30.